当前位置: 首页 > 期刊 > 《医学信息》 > 2017年第14期
编号:13058702
左乙拉西坦单药治疗Lennox—Gastaut综合征的疗效观察(4)
http://www.100md.com 2017年4月9日 《医学信息》 2017年第14期
     [21]Sharpe DV,Patel AD,Abou-Khalil B,et al.Levetiracetam monotherapy in juvenile myoelonie epilepsy[J].Seizure,2008,17(1):64-68.

    [22]Callenhach PM,Arts WF,Houten R,et al.Add-on levetiracetam in children and adolescents with refractory epilepsy:Results of an open-label muh-centre study[J].Eur J Paediatr Neurol,2008,12(4):321-327.

    [23]Verrotti A,Coppola G,Manco R,et al.Levetiracetam monotherapy for children and adolescents with benign rolandic seizures[J].Seizure,2007,16(3):271-275.

    [24]吳洵畎,洪震,吴逊,等.多中心双盲、随机、安慰剂对照评价左乙拉西坦添加治疗难治性部分性癫痫发作的疗效及安全性[J].中华神经科杂志,2007,40(3):149-153.

    [25]Grosso S,Cordelli DM,Franzoni E,et al.Efficacy and safety of levetira-eetam in infants and young chlidren with refractory epilepsy[J].Seizure,2007,16(4):345-350.

    [26]Silverstein FS,Ferriero DM.Off-label use of antiepileptie drugs for the treatement of neonatal seizure[J].J Pediatr Neurol,2008,39(2):77-79.

    [27]Krief P,Li Kan,Maytal J.Efficacy of levetiracetam in children with epilespy younger than 2 years of age[J].J Child Neural,2008,23(5):582-584.编辑/杨倩, 百拇医药(李振宏 黄郁波 黄涛)
上一页1 2 3 4